Phibro Animal Health (PAHC) Total Non-Current Liabilities (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Total Non-Current Liabilities of $1.1 billion in Q1 2026, up 1.07% quarter-over-quarter from $1.1 billion in Q4 2025, and up 4.13% on a YoY basis from $1.0 billion in Q1 2025.
Phibro Animal Health (PAHC) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
Phibro Animal Health's Total Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 4.13% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 4.13% YoY), while the FY2025 annual figure was $995.9 million, up 38.57% from the prior year.
- Total Non-Current Liabilities was $1.1 billion for Q1 2026 at Phibro Animal Health, up from $1.1 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.1 billion in Q1 2026 to a low of $608.8 million in Q2 2022.
- Historically, Total Non-Current Liabilities has averaged $796.9 million across 5 years, with a median of $701.9 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities retreated 6.97% in 2023, then soared 52.4% in 2024.
- A 5-year view of Total Non-Current Liabilities shows it stood at $684.3 million in 2022, then decreased by 6.97% to $636.6 million in 2023, then jumped by 52.4% to $970.1 million in 2024, then advanced by 10.36% to $1.1 billion in 2025, then increased by 1.07% to $1.1 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.07 Bn |
| Sep 30, 2025 | 1.06 Bn |
| Jun 30, 2025 | 995.91 Mn |
| Mar 31, 2025 | 1.04 Bn |
| Dec 31, 2024 | 970.13 Mn |
| Sep 30, 2024 | 707.11 Mn |
| Jun 30, 2024 | 718.70 Mn |
| Mar 31, 2024 | 701.94 Mn |
| Dec 31, 2023 | 636.59 Mn |
| Sep 30, 2023 | 631.07 Mn |
| Jun 30, 2023 | 682.81 Mn |
| Mar 31, 2023 | 686.96 Mn |
| Dec 31, 2022 | 684.29 Mn |
| Sep 30, 2022 | 624.24 Mn |
| Jun 30, 2022 | 608.76 Mn |
| Mar 31, 2022 | 643.51 Mn |
| Dec 31, 2021 | 603.79 Mn |
| Sep 30, 2021 | 546.60 Mn |
| Jun 30, 2021 | 546.83 Mn |